niraparib tosilate monohydrate - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
Product details |
Supply Impact Dates |
Further Details |
ZEJULA niraparib (as tosilate monohydrate) 100 mg capsule blister pack AUST R: 305254Active ingredients:
niraparib tosilate monohydrate
Dosage form: Capsule, hard
Sponsor: GlaxoSmithKline Australia Pty Ltd
Phone: 1800033109
|
Deletion from market:
31 Jan 2025
|
Shortage status: To be discontinued
Availability: Reduction in supply until supply is exhausted
Reason: Commercial Changes / Commercial viability
Management action: Other generic by same sponsor is available. ZEJULA niraparib (as tosilate monohydrate) 100 mg film-coated tablet blister pack ARTG 395406
|